돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2275341생성일: 2026년 10월 26일

1,1'-Carbonyldiimidazole → (R)-N-(5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide

https://huagongshe.com/reaction/2275341

반응식

참여 물질

역할이름HCID투입량
반응물1,1'-CarbonyldiimidazoleHCID 68263—
반응물DiisopropylethylamineHCID 81531—
반응물3-Hydroxyazetidine hydrochlorideHCID 2759290—
반응물(R)-5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amineHCID 67330330—
용매DichloromethaneHCID 6344—
생성물(R)-N-(5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamideHCID 5838625685.1%

반응 단계

To a DCM (0.8 mL) solution of (R)-5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (30 mg, 0.090 mmol) was added CDI (29 mg, 0.18 mmol) at ambient temperature in one portion. After stirring two hours, azetidin-3-ol hydrochloride (20 mg, 0.18 mmol) was added in one portion, followed by addition of DIEA (0.047 mL, 0.27 mmol). The reaction was stirred for 5 minutes before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 5 to 50% acetonitrile/water to yield the final product as a yellowish foamy powder (33 mg, 85% yield). MS (apci) m/z=431.1 (M+H).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09127013B2
출처 데이터셋uspto-grants-2015_09
ORD IDord-297fafc744d141038cbd7fa936ea3b9d
출처 메모uspto-grants-2015_09